In recent developments, two significant advancements in the tech and health sectors have garnered attention. First, leading pharmaceutical companies, Eli Lilly and Novo Nordisk, have reported that their popular GLP-1 weight-loss drugs may also contribute to the deceleration of biological aging. These medications, known for aiding weight management, are now being examined for their potential effects on aging processes. Researchers have utilized molecular aging clocks, which analyze changes in DNA and key protein levels, to track these effects. The findings suggest that patients using GLP-1 drugs might experience a slower aging process, sparking discussions about the possibility of these drugs functioning as genuine longevity treatments. However, the implications of these results warrant further investigation to understand the broader impacts on aging and health.
On the technological front, Energy Dome is capturing attention as a Climate Tech Company to Watch, recognized for its innovative approach to energy storage. The company has developed a unique system utilizing compressed carbon dioxide to create batteries capable of storing renewable energy, addressing the inherent variability of solar and wind power. Traditional energy storage solutions often rely on specific geological conditions, but Energy Dome’s technology aims to provide a scalable solution that can be implemented globally. By compressing carbon dioxide for energy storage, the company is positioning itself to enhance grid reliability and promote the integration of renewable energy sources. As climate change continues to be a pressing issue, advancements like those from Energy Dome represent critical steps toward sustainable energy solutions.
Source: The Download: weight-loss drugs slowing aging and carbon dioxide batteries via MIT Technology Review